Cefazolin PK Study 3g vs 2g

NCT05309304 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Cefazolin

Sponsor

Baxter Healthcare Corporation